Emily Hsu, MD

Emily Hsu, MD


Emily Hsu, MD, is a board-certified oncologist with the Lifespan Cancer Institute. She received her medical degree from the St. George’s University School of Medicine. She completed an internal medicine residency at the University of Massachusetts Medical School and a hematology/oncology fellowship at the University of Connecticut.

Dr. Hsu has published research on topics such as the role of proteins in mesenchymal stem cell differentiation, the importance of tissue diagnosis in cardiac lymphoma, and the impact of COVID-19 on patients with cancer.

She is a member of the American Society of Clinical Oncology and the American Society of Hematology.



Hematology Oncology, Rhode Island Hospital
Ambulatory Patient Center (APC Building) (directions)
110 Lockwood St.
Providence, RI 02903

Lifespan Cancer Institute, Newport Hospital
Newport Hospital (directions)
20 Powel Avenue, Turner Building, 1st Floor
Newport, RI 02840


  • Medical School:  St. George's University (Grenada, West Indies)
  • Fellowship:  University of Connecticut Health Center
  • Residency:  University of Massachusetts